Literature DB >> 16060150

Folate conjugated fluorescent silica nanoparticles for labeling neoplastic cells.

Swadeshmukul Santra1, Bernd Liesenfeld, Debamitra Dutta, David Chatel, Christopher D Batich, Weihong Tan, Brij M Moudgil, Robert A Mericle.   

Abstract

We describe a novel technique of using fluorescent silica nanoparticles (FSNPs) to detect over-expressed folate receptors, as typical for certain malignancies (metastatic adenocarcinoma, pituitary adenoma and others). Using Stöber's method with some modification, 135 nm size FSNPs were synthesized by a hydrolysis and co-condensation reaction of tetraethylorthosilicate (TEOS), fluorescein labeled (3-aminopropyl)triethoxysilane (APTS) and a water-dispersible silane reagent, (3-trihydroxysilyl)propyl methylphosphonate (THPMP) in the presence of ammonium hydroxide catalyst. Folic acid (folate) was covalently attached to the amine modified FSNPs by a carbodiimide coupling reaction. The characterization of folate-FSNPs was performed using a variety of spectroscopic (UV-VIS and fluorescence), microscopic (transmission electron microscopy, TEM) and light scattering techniques. Folate conjugated FSNPs were then targeted to human squamous cancer cells (SCC-9). Laser scanning confocal images successfully demonstrated the labeling of SCC-9 cells and the efficacy of FSNP based detection system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16060150     DOI: 10.1166/jnn.2005.146

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  16 in total

1.  Nonporous Silica Nanoparticles for Nanomedicine Application.

Authors:  Li Tang; Jianjun Cheng
Journal:  Nano Today       Date:  2013-06       Impact factor: 20.722

2.  Nanoparticle imaging of integrins on tumor cells.

Authors:  Xavier Montet; Karin Montet-Abou; Fred Reynolds; Ralph Weissleder; Lee Josephson
Journal:  Neoplasia       Date:  2006-03       Impact factor: 5.715

Review 3.  Current status and contemporary approaches to the discovery of antitumor agents from higher plants.

Authors:  Garima Agarwal; Peter J Blanco Carcache; Ermias Mekuria Addo; A Douglas Kinghorn
Journal:  Biotechnol Adv       Date:  2019-01-08       Impact factor: 14.227

4.  Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.

Authors:  Jie Lu; Monty Liong; Zongxi Li; Jeffrey I Zink; Fuyuhiko Tamanoi
Journal:  Small       Date:  2010-08-16       Impact factor: 13.281

Review 5.  Nanoparticles in the brain: a potential therapeutic system targeted to an early defect observed in many neurodegenerative diseases.

Authors:  Shermali Gunawardena
Journal:  Pharm Res       Date:  2013-04-27       Impact factor: 4.200

6.  Multispectral molecular imaging of capillary endothelium to facilitate preoperative endovascular brain mapping.

Authors:  H Charles Manning; Sheila D Shay; Robert A Mericle
Journal:  J Neurosurg       Date:  2009-05       Impact factor: 5.115

7.  In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles.

Authors:  Rajiv Kumar; Indrajit Roy; Tymish Y Ohulchanskky; Lisa A Vathy; Earl J Bergey; Munawwar Sajjad; Paras N Prasad
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

8.  In vivo imaging of sentinel nodes using fluorescent silica nanoparticles in living mice.

Authors:  Yong Hyun Jeon; Young-Hwa Kim; Kihwan Choi; Jing Yu Piao; Bo Quan; Yun-Sang Lee; Jae Min Jeong; June-Key Chung; Dong Soo Lee; Myung Chul Lee; Jaetae Lee; Doo Soo Chung; Keon Wook Kang
Journal:  Mol Imaging Biol       Date:  2009-10-15       Impact factor: 3.488

9.  Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.

Authors:  Rolando E Yanes; Derrick Tarn; Angela A Hwang; Daniel P Ferris; Sean P Sherman; Courtney R Thomas; Jie Lu; April D Pyle; Jeffrey I Zink; Fuyuhiko Tamanoi
Journal:  Small       Date:  2012-11-14       Impact factor: 13.281

10.  Drug/dye-loaded, multifunctional iron oxide nanoparticles for combined targeted cancer therapy and dual optical/magnetic resonance imaging.

Authors:  Santimukul Santra; Charalambos Kaittanis; Jan Grimm; J Manuel Perez
Journal:  Small       Date:  2009-08-17       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.